Quintiles - IQV Sales Growth YoY (Last Twelve Months)

Public company logo of Quintiles (IQV)

IQVIA Holdings Inc. (IQV) balances the organization of global trials with the delivery of deep healthcare analytics. This chart of LTM sales volume changes year-over-year visualizes this strategy, where the 8.80 level captures the current state. The trend relies on EBITDA margins and new order volume, although a full impulse from AI implementation and the stabilization of biopharma budgets is only now beginning to form.

Sales Growth YoY (TTM): IQVIA (IQV) for 02/11/2024 - 11/19/2026

IQVIA (IQV) - metric breakdowns and financial figures

Analysis of all company metrics:IQVIA Holdings Inc.
Brand item of iqvia.com

Investors should utilize this indicator to stress-test revenue resilience by evaluating the growth rates of trailing twelve-month (TTM) turnover relative to the previous year. This TTM sales volume trend reflects the commercialization efficiency of drugs and the demand for clinical trials at IQVIA Holdings Inc. (IQV), where extreme values signal either a peak in expansion or a risk of business stagnation.